Remedium Lifecare Ltd Q3 FY23 net profit slips QoQ to Rs. 152.17 crores

Remedium Lifecare Ltd has reported Standalone financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 176.5012 crores during the period ended December 31, 2022 as compared to Rs. 160.0244 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 1.5217 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 2.1896 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 4.23 for the period ended December 31, 2022 as compared to Rs. 6.08 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹176.5012 crs	₹160.0244 crs	10.30%
Net Profit	₹1.5217 crs	₹2.1896 crs	-30.50%
EPS	₹4.23	₹6.08	-30.43%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.176.5012 crores during the period ended December 31, 2022 as compared to Rs.206.0498 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.1.5217 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.0.6868 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.4.23 for the period ended December 31, 2022 as compared to Rs.1.91 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹176.5012 crs	₹206.0498 crs	-14.34%
Net Profit	₹1.5217 crs	₹0.6868 crs	121.56%
EPS	₹4.23	₹1.91	121.47%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.435.8531 crores during the 9 Months period ended December 31, 2022 as compared to Rs.464.5034 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.10.2074 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.2.2412 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.28.35 for the 9 Months period ended December 31, 2022 as compared to Rs.6.23 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹435.8531 crs	₹464.5034 crs	-6.17%
Net Profit	₹10.2074 crs	₹2.2412 crs	355.44%
EPS	₹28.35	₹6.23	355.06%

Shares of Remedium Lifecare Ltd was last trading in BSE at Rs. 261.10 as compared to the previous close of Rs. 255.10. The total number of shares traded during the day was 420 in over 21 trades.

The stock hit an intraday high of Rs. 265.00 and intraday low of 255.00. The net turnover during the day was Rs. 108223.00.

Source : Equity Bulls

Keywords

RemediumLifecare Q3FY23 9MFY23 ResultUpdate